Since July 2018, a number of certain types of medications used to treat hypertension (high blood pressure) and other heart conditions have been recalled by the manufacturers, according to a statement issued by the Food and Drug Administration (FDA). These are drugs containing amlodipine in combination with valsartan or losartan or hydrochlorothiazide HCTZ in combination with valsartan or losartan.
This recall, which has been expanded several times, is due to possible contamination with trace amounts of N-Nitrosodiethylamine (NDEA), which is classified as a Group 2A carcinogen (possible cancer-causing agent) by the World Health Organization.
The FDA is testing and investigating all angiotensin II receptor blockers (ARBs) for the presence of NDEA. People who are taking an ARB, including those that have been recalled, are advised to continue taking their medicine until they are provided a replacement by their doctor or pharmacist.
Sourced from: FDA